Endocannabinoid system, a target to improve cognitive disorders in models of Down syndrome
A study by the Neuropharmacology Laboratory-NeuroPhar of the Department of Experimental and Health Sciences (DCEXS) at UPF reveals the involvement of the endocannabinoid system in cognitive disorders in mouse models of Down ...
Feb 7, 2019
0
3